Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
<p><strong>Background:</strong> Hydroxychloroquine has recently received Emergency Use Authorization by the FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and in combination with azithromyc...
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Working paper |
| Language: | English |
| Published: |
Cold Spring Harbor Laboratory Press
2020
|